Navigation Toggle Navigation
OncoSec was incorporated in the state of Nevada in 2011.
OncoSec became a public company in 2011.
OncoSec’s stock is traded on the NASDAQ Capital Market under the symbol ONCS.
The CUSIP number of OncoSec’s common stock is 68234L207.
Not currently. OncoSec is a speculative growth stock. Dividends are normally paid from earnings and OncoSec does not currently generate earnings and profits.
Visit www.oncosec.com to join our mailing list.
Visit our events page at www.oncosec.com/events and join our mailing list to be notified of upcoming presentations.
Management team profiles are available at www.oncosec.com/who-we-are.
OncoSec’s fiscal year ends July 31.
OncoSec’s headquarters are located at 3565 General Atomics Ct., San Diego, CA 92121. The main phone for this location is (858) 662-6732.
OncoSec is covered by the analysts listed below. For more information, please visit: http://ir.oncosec.com/analyst-coverage.
Mark Breidenbach - H.C. Wainwright
Jason Kolbert – Maxim Group
Rahul Jasuja – Noble Life Science Partners
Mayer Hoffman McCann P.C.
10616 Scripps Summit Court
San Diego, CA 92131
Morrison & Foerster LLP
12531 High Bluff Drive
San Diego, CA 92130